|
Awl-II-38.3
|
A986592-10mg
|
≥99% |
1135205-94-5 |
10mg
|
¥ 3400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Adenosine antagonist-1
|
A985284-5mg
|
≥99% |
431040-19-6 |
5mg
|
¥ 5796.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Adenosine antagonist-1
|
A985284-1mg
|
≥99% |
431040-19-6 |
1mg
|
¥ 2580.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3alpha,7alpha,12beta-Trihydroxy-5beta-cholanic acid
|
A985070-5mg
|
≥99% |
71883-64-2 |
5mg
|
¥ 2300.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3alpha,7alpha,12beta-Trihydroxy-5beta-cholanic acid
|
A985070-1mg
|
≥99% |
71883-64-2 |
1mg
|
¥ 500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3alpha,7alpha,12beta-Trihydroxy-5beta-cholanic acid
|
A985070-10mg
|
≥99% |
71883-64-2 |
10mg
|
¥ 4200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
溴化乙酰胆碱-d
|
A982545-5mg
|
≥98% |
93449-32-2 |
5mg
|
¥ 1800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
溴化乙酰胆碱-d
|
A982545-1mg
|
≥98% |
93449-32-2 |
1mg
|
¥ 700.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
溴化乙酰胆碱-d
|
A982545-10mg
|
≥98% |
93449-32-2 |
10mg
|
¥ 2900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/18:0)
|
A981844-1mg
|
≥98% |
124579-05-1 |
1mg
|
¥ 4960.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(Aminomethyl)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
A980458-50mg
|
≥98% |
1010100-22-7 |
50mg
|
¥ 1400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(Aminomethyl)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
A980458-25mg
|
≥98% |
1010100-22-7 |
25mg
|
¥ 880.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(Aminomethyl)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
A980458-100mg
|
≥98% |
1010100-22-7 |
100mg
|
¥ 2200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-Amino-8-Cyclopentyl-4-Methyl-6-(1h-Pyrazol-4-Yl)pyrido[2,3-D]pyrimidin-7(8h)-One
|
A980292-1mg
|
≥99% |
1013098-90-2 |
1mg
|
¥ 10685.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
异常山碱
|
A980130-5mg
|
≥98% |
32434-44-9 |
5mg
|
¥ 1300.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
异常山碱
|
A980130-1mg
|
≥98% |
32434-44-9 |
1mg
|
¥ 520.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
异常山碱
|
A980130-10mg
|
≥98% |
32434-44-9 |
10mg
|
¥ 2100.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3aR,5R,6R,7R,7aR)-5-(acetoxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]oxazole-6,7-diyl diacetate
|
A978414-5mg
|
≥98% |
10378-06-0 |
5mg
|
¥ 500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3aR,5R,6R,7R,7aR)-5-(acetoxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]oxazole-6,7-diyl diacetate
|
A978414-50mg
|
≥98% |
10378-06-0 |
50mg
|
¥ 1600.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3aR,5R,6R,7R,7aR)-5-(acetoxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]oxazole-6,7-diyl diacetate
|
A978414-10mg
|
≥98% |
10378-06-0 |
10mg
|
¥ 800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3aR,5R,6R,7R,7aR)-5-(acetoxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]oxazole-6,7-diyl diacetate
|
A978414-100mg
|
≥98% |
10378-06-0 |
100mg
|
¥ 2500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-amino-1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
|
A977441-5mg
|
≥98% |
13913-16-1 |
5mg
|
¥ 5700.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-amino-1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
|
A977441-1mg
|
≥98% |
13913-16-1 |
1mg
|
¥ 1900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Argadin
|
A976994-1mg
|
≥98% |
289665-92-5 |
1mg
|
¥ 5000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |